Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Cubist Pharmaceuticals Inc (CBST)    
$61.40 1.11 (1.78%) as of 4:30 Mon 7/28


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 75,300,000 as of 12/25
Market Cap: 4.62(B)
Last Volume: 1,021,082 Avg Vol: 962,202
52 Week Range: $55.9 - $81.23
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY       NASDAQ COMPOSITE  
    NASDAQ NNM COMPOSITE  

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  1054
Guru Rank Value     : 0
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Cubist Pharmaceuticals is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. Co. has three marketed products: CUBICIN® (daptomycin for injection), a once-daily, bactericidal, intravenous antibiotic with activity against certain Gram-positive organisms; ENTEREG (alvimopan), an oral, peripherally-acting mu opioid receptor antagonist approved to accelerate upper and lower gastrointestinal recovery following partial large or small bowel resection surgery with primary anastomosis; and DIFICID (fidaxomicin) for the treatment of clostridium difficile-associated diarrhea.

 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 31,053 204,202 420,472 870,846
Total Sell Value $2,115,294 $15,972,127 $30,570,889 $51,933,633
Total People Sold 5 8 10 13
Total Sell Transactions 9 22 36 83
End Date 2014-04-27 2014-01-24 2013-07-26 2012-07-26

   
Records found: 642
  Page 1 of 26  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Perez Robert J President & COO   •       •      –    2014-06-30 4 A $57.87 $19,328 D/D 334 46,203     -
   Gilman Steven C EVP & Chief Scientific Officer   •       •      –    2014-06-30 4 A $69.82 $7,471 I/I 107 2,851     -
   Stea Gregory SVP, Commercial Operations   •       •      –    2014-06-30 4 A $69.82 $7,331 I/I 105 539     -
   Desrosier Thomas EVP, Chief Legaland Administra   •       •      –    2014-06-30 4 A $57.87 $12,326 D/D 213 1,822     -
   Desrosier Thomas EVP, Chief Legaland Administra   •       •      –    2014-06-30 4 A $69.82 $6,214 I/I 89 431     -
   Tomsicek Michael John SVP & Chief Financial Officer   •       •      –    2014-06-30 4 A $69.82 $5,725 I/I 82 1,136     -
   Bonney Michael W Chief Executive Officer   •       •      –    2014-06-30 4 A $57.87 $21,238 D/D 367 176,226     -
   Lawton Alison Francis Director   •       •      –    2014-06-03 4 OE $0.00 $0 D/D 1,104 4,717     -
   Henney Jane E Md Director   •       •      –    2014-06-03 4 A $0.00 $0 D/D 899 3,540     -
   Henney Jane E Md Director   •       •      –    2014-06-03 4 OE $0.00 $0 D/D 1,104 4,644     -
   Corrigan Mark Director   •       •      –    2014-06-03 4 A $0.00 $0 D/D 899 6,397     -
   Corrigan Mark Director   •       •      –    2014-06-03 4 OE $0.00 $0 D/D 1,104 7,501     -
   Hutson Nancy J Director   •       •      –    2014-06-03 4 OE $0.00 $0 D/D 1,104 5,951     -
   Bate Kenneth Director   •       •      –    2014-06-03 4 OE $0.00 $0 D/D 1,701 9,615     -
   Soeters Martinus Hermanus Director   •       •      –    2014-06-03 4 OE $0.00 $0 D/D 1,104 10,397     -
   Lawton Alison Francis Director   •       •      –    2014-06-03 4 A $0.00 $0 D/D 899 3,613     -
   Moulder Leon O Jr Director   •       •      –    2014-06-03 4 A $0.00 $0 D/D 899 9,997     -
   Moulder Leon O Jr Director   •       •      –    2014-06-03 4 OE $0.00 $0 D/D 1,104 11,101     -
   Bonney Michael W Chief Executive Officer   •       •      –    2014-05-15 4 AS $67.50 $204,930 D/D (3,036) 175,859 -6%     
   Gilman Steven C EVP & Chief Scientific Officer   •       •      –    2014-05-15 4 OE $16.76 $253,495 D/D 15,125 42,723     -
   Gilman Steven C EVP & Chief Scientific Officer   •       •      –    2014-05-15 4 AS $67.45 $1,108,240 D/D (16,340) 27,598 -6%     
   Perez Robert J President & COO   •       •      –    2014-05-15 4 AS $67.50 $102,465 D/D (1,518) 45,869 -6%     
   Stea Gregory SVP, Commercial Operations   •       •      –    2014-05-15 4 AS $67.50 $59,063 D/D (875) 18,136 -6%     
   Perez Robert J President & COO   •       •      –    2014-05-14 4 OE $0.00 $0 D/D 3,125 47,387     -
   Perez Robert J President & COO   •       •      –    2014-05-14 4 AS $69.00 $165,600 D/D (2,400) 44,262 -10%     

  642 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 26
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed